Trial
NCT00929669
Effect of Pasireotide Long Acting Release (LAR) on Gonadotroph Adenomas
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Pennsylvania
Collaborators
—
Condition
Gonadotroph Adenomas
Intervention
pasireotide LAR
Why stopped
unable to identify a third subject
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-11-28